MORRISTOWN, N.J., March 18, 2020 /PRNewswire/ — In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, GSK was ranked as the top company delivering superior customer value and sales force engagement, as well as delivering therapeutic innovation in the asthma market according to pulmonary disease specialists. The research was conducted in February 2020, using KMK’s Rapid Pulse Survey platform. AstraZeneca, Genentech, and Novartis rounded out the top organizations driving innovation and customer value in this space.
{iframe}https://www.prnewswire.com/news-releases/gsk-astrazeneca-genentech-and-novartis-identified-as-the-top-companies-driving-therapeutic-innovation-in-asthma-301026060.html{/iframe}